卒中后内皮与白细胞来源微囊泡与心血管风险:PROSCIS-B研究
主要复合终点为复发性卒中、心肌梗死和全因死亡。内皮微囊泡和白细胞来源微囊泡最高四分位水平与3年内不良心血管结局独立相关,提示内皮功能障碍和血管炎症影响卒中长期预后。
要点
- 卒中后高水平的EMV和LMV与3年内复发性卒中、心肌梗死或全因死亡风险增加相关。
- EMV和LMV可能有助于卒中患者的心血管风险预测。
- 该研究为II级证据,支持内皮功能障碍和血管炎症影响卒中长期预后。
核心结论
- 卒中后高水平的EMV和LMV与3年内更差的心血管结局相关。
- 内皮功能障碍和血管炎症影响卒中后长期预后,EMV和LMV可能用于风险预测。
研究设计与样本
- 用流式细胞术检测柠檬酸盐血中EMV、LMV、MMV和PMV水平。
- 主要复合终点为复发性卒中、心肌梗死和全因死亡。
主要发现
- 共发生95个终点事件。
- EMV最高四分位组相比最低四分位组的调整HR为2.5(95%CI 1.2-4.9)。
- LMV最高四分位组相比最低四分位组的调整HR为3.1(95%CI 1.4-6.8)。
- PMV的关联较弱(HR 1.7,95%CI 0.9-3.2),MMV无关联(HR 1.1,95%CI 0.6-1.8)。
临床怎么用
- 对轻型卒中幸存者可考虑检测EMV和LMV以辅助长期心血管风险分层。
- 针对内皮功能障碍和血管炎症的干预可能改善卒中后长期预后。
局限性
- 研究为观察性队列,不能确立因果关系。
- 证据级别为Class II,结论需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine the role of circulating microvesicles (MV) on long-term cardiovascular outcomes after stroke, we measured them in patients with first-ever stroke with a 3-year follow-up. METHODS: In the Prospective Cohort With Incident Stroke Berlin (PROSCIS-B), patients with first-ever ischemic stroke were followed up for 3 years. The primary combined endpoint consisted of recurrent stroke, myocardial infarction, and all-cause mortality. Citrate-blood levels of endothelial MV (EMV), leukocyte-derived MV (LMV), monocytic MV (MMV), and platelet-derived MV (PMV) were measured with flow cytometry. Kaplan-Meier curves and adjusted Cox proportional hazards models were used to estimate the effect of MV levels on the combined endpoint. RESULTS: Five hundred seventy-one patients were recruited (median age 69 years, 39% female, median NIH Stroke Scale score 2, interquartile range 1-4), and 95 endpoints occurred. Patients with levels of EMV (adjusted hazard ratio [HR] 2.5, 95% confidence interval [CI] 1.2-4.9) or LMV (HR 3.1, 95% CI 1.4-6.8) in the highest quartile were more likely to experience an event than participants with lower levels with the lowest quartile used as the reference category. The association was less pronounced for PMV (HR 1.7, 95% CI 0.9-3.2) and absent for MMV (HR 1.1, 95% CI 0.6-1.8). CONCLUSION: High levels of EMV and LMV after stroke were associated with worse cardiovascular outcome within 3 years. These results reinforce that endothelial dysfunction and vascular inflammation affect the long-term prognosis after stroke. EMV and LMV might play a role in risk prediction for stroke patients. CLINICALTRIALSGOV IDENTIFIER: NCT01363856. CLASSIFICATION OF EVIDENCE: This study provides Class II evidence of the effect of MV levels on subsequent stroke, myocardial infarction, or all-cause mortality in survivors of mild stroke.
引用
- Huo S, Kränkel N, Nave AH, et al. Endothelial and Leukocyte-Derived Microvesicles and Cardiovascular Risk After Stroke: PROSCIS-B. Neurology. 2020. PMID: 33184230. doi:10.1212/WNL.0000000000011223
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。